	Israel Securities Authority			Tel Aviv Stock Exchange		C003 ( Public )		Reported via MAGNA:	05/11/2018
	www.isa.gov.il			www.tase.co.il				Reference:	2018-02-104463	Time of broadcast: 15:23 15:19:58

Other Report or Announcement

Regulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

Please note that in the case of delayed publication of report, no changes will be allowed after the form is submitted.

Delay the publication of a report

_________

1. The delay of the report can be done up to 72 hours maximum from the date of filling out the form.

2. Attention that in accordance with the provisions of the law, the reporting date must be simultaneous with the report in the foreign exchange.

The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on

Press Release

ORAMEDPHARMINC_PR_20181105_isa.pdf


References of previous documents relating to this matter(the reference does not constitute incorporation by reference):



Stock Exchange/Market: NASDAQ CM	Date of revision of form structure: 04/09/2018
Address: 142 W 57th St. 11th floor 0 , New York 10019 New York , USA Tel: 844-9672633 , 02-5660001 Fax: 02-5660004
E-mail address: office@oramed.com Company site: www.oramed.com

Previous names of reporting entity:

Name of the Signatory: EISENBERG AVIZOHAR Hilla Position of Signatory in the reporting corporation: CFO & Secretary Name of Employer Company:
Address: Hi-Tech Park, Givat Ram 2/4 , Jerusalem 91390 Telephone: 02-5660001 Facsimile: 02-5660004 E-mail: hilla@oramed.com 2
USA